MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
University of Zurich · University Hospital of Zurich · +6 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
785
total citations
- FWCI
- 24.30
- Percentile
- 100%
- References
- 94
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Temozolomide
- Medicine
- DNA methylation
- Glioma
- Methyltransferase
- Gene silencing
- O-6-methylguanine-DNA methyltransferase
- Biomarker
No related works found for this paper.